Meghann McManus
Pediatric Hematology-Oncology · Nashville, TNNPI 1366572505
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,262 of the $4,330 with a category attached, or 75.3%. 36 manufacturers reported payments, led by CSL Behring at 27.3% of the total.
Across 129 payments — averaging $33.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$1K
- Jazz Pharmaceuticals Inc.$417
- Novo Nordisk$299
- Abbott$268
- Pfizer$254
- Sobi, Inc$218
- plus $2K from 30 others
Across 2 payments — averaging $133,381 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$267K
What the payments were for
- Speaking & faculty fees$98523%
- Food & beverage$3,26275%
- Education$832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 9 | $1,184 |
| Jazz Pharmaceuticals Inc. | 6 | $417 |
| Novo Nordisk | 11 | $299 |
| Abbott | 8 | $268 |
| Pfizer | 13 | $254 |
| Sobi, Inc | 6 | $218 |
| Springworks Therapeutics, Inc. | 6 | $146 |
| Pharming Healthcare, Inc. | 6 | $145 |
| Azurity Pharmaceuticals, Inc. | 6 | $119 |
| Agios Pharmaceuticals, Inc. | 6 | $114 |
| Sanofi-aventis U.S. LLC | 4 | $98 |
| Novartis | 4 | $92 |
| UCB, Inc. | 3 | $85 |
| Genentech USA, Inc. | 3 | $81 |
| Amgen | 4 | $79 |
| Y-mabs Therapeutics, Inc. | 3 | $77 |
| Syndax Pharmaceuticals, Inc. | 3 | $75 |
| HEMA Biologics, LLC | 3 | $62 |
| Sanofi | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Biogen | 2 | $48 |
| Day One Biopharmaceuticals | 2 | $48 |
| Seagen Inc. | 3 | $44 |
| USWM, LLC | 1 | $37 |
| Bayer | 1 | $30 |
| RARE Disease Therapeutics, Inc. | 1 | $24 |
| X4 Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca | 1 | $21 |
| Medexus Pharma, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Livanova USA, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $17 |
| Aucta Pharmaceuticals, Inc. | 1 | $16 |
| Neurelis, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,330 in reported general payments places this provider in the 60th percentile of 113 pediatric hematology-oncology providers in Tennessee.
See all pediatric hematology-oncology providers in Tennessee →
Other pediatric hematology-oncology in Nashville
- Jennifer DommNashville$359K
- Haydar FrangoulNashville$356K
- Carrie KitkoNashville$51K
- Michael DebaunNashville$39K
- Alexandra BorstNashville$27K
- James ConnellyNashville$21K
- Scott BorinsteinNashville$21K
- Clinton CarrollNashville$8K
- Heather McDanielNashville$8K
- Elizabeth YangNashville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.